William Sheremata - Concepedia

Author

William Sheremata

Also Known As

John Schaeffer, W A Sheremata, W Sheremata, W. A. Sheremata, W. SHEREMATA, W. Sheremata, W.A. Sheremata, WILLIAM A. SHEREMATA, WILLIAM SHEREMATA, William A Sheremata

101

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Miami University of Toronto Montreal Neurological Institute and Hospital National Institutes of Health SUNY Upstate Medical University

About

William Sheremata is an author at University of Miami specializing in medicine, neurology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.6K
2	Health Sciences	6	6	405
3	Allergy	5	5	289
4	Public Health	3	3	107
5	Allergy Medicine	1	1	11

William Sheremata

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis David H. Miller, Omar Khan, William Sheremata, New England Journal of Medicine	2003	1.2K
Multiple sclerosis and human T-cell lymphotropic retroviruses Hilary Koprowski, E DeFreitas, Mary‐Ellen Harper, Nature Autoimmune DiseaseHuman RetrovirusImmunologyAutoimmunityChronic Viral Infection	1985	349
Evidence of platelet activation in multiple sclerosis William Sheremata, Wenche Jy, Lawrence L. Horstman, Journal of Neuroinflammation	2008	172
Randomized multicenter trial of natalizumab in acute MS relapses P. O’Connor, Andrew Goodman, A. Willmer–Hulme, Neurology	2004	166
Impact of rituximab on relapse rate and disability in neuromyelitis optica Gurdesh S Bedi, Andrew Brown, Sylvia Delgado, Multiple Sclerosis Journal	2011	149
The Guillain-Barré Syndrome and Multiple Sclerosis Ross E. Rocklin, William Sheremata, Robert G. Feldman, New England Journal of Medicine Neurological DisorderImmunologyPeripheral NervesImmunotherapyNeuroinflammation	1971	141
Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis Steven Jacobson, Vladimir Zaninovic, Carlos A. Mora, Annals of Neurology	1988	126
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS William Sheremata, Timothy R. Vollmer, Lael A. Stone, Neurology Ms. Serum ConcentrationsIntravenous NatalizumabMetronomic TherapyPharmacologyPharmacokinetic Study	1999	126
Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection Joseph R. Berger, William Sheremata, Lionel Resnick, Neurology Primary ImmunodeficiencyMultiple Sclerosis‐like IllnessNeurological DisorderMedicineImmunodeficiencies	1989	116
Spastic ataxia associated with human T‐cell lymphotrophic virus type II infection William J. Harrington, William Sheremata, Brain Hjelle, Annals of Neurology	1993	111

Page 1